Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Schizophrenia

  Free Subscription


13.06.2022

2 Biol Psychiatry
2 Mol Psychiatry
1 PLoS One
5 Psychiatry Res
2 Psychol Med
2 Schizophr Res


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Biol Psychiatry

  1. KUSHIMA I, Nakatochi M, Aleksic B, Okada T, et al
    Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder.
    Biol Psychiatry. 2022 Apr 22. pii: S0006-3223(22)01197.
    PubMed         Abstract available

  2. SUN J, Zhang X, Cong Q, Chen D, et al
    miR143-3p-Mediated NRG-1-Dependent Mitochondrial Dysfunction Contributes to Olanzapine Resistance in Refractory Schizophrenia.
    Biol Psychiatry. 2022 Mar 26. pii: S0006-3223(22)01131.
    PubMed         Abstract available


    Mol Psychiatry

  3. AKINGBUWA WA, Hammerschlag AR, Bartels M, Nivard MG, et al
    Ultra-rare and common genetic variant analysis converge to implicate negative selection and neuronal processes in the aetiology of schizophrenia.
    Mol Psychiatry. 2022 Jun 3. pii: 10.1038/s41380-022-01621.
    PubMed         Abstract available

  4. OLIVER D, Arribas M, Radua J, Salazar de Pablo G, et al
    Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis.
    Mol Psychiatry. 2022 Jun 3. pii: 10.1038/s41380-022-01611.
    PubMed         Abstract available


    PLoS One

  5. FAULKNER SM, Drake RJ, Ogden M, Gardani M, et al
    A mixed methods expert opinion study on the optimal content and format for an occupational therapy intervention to improve sleep in schizophrenia spectrum disorders.
    PLoS One. 2022;17:e0269453.
    PubMed         Abstract available


    Psychiatry Res

  6. KIRSCHENBAUM MA, Lopez LV, de Filippis R, Ali AF, et al
    Validation of a novel Psychosis-Implicit Association Test (P-IAT) as a diagnostic support tool.
    Psychiatry Res. 2022;314:114647.
    PubMed         Abstract available

  7. LI Z, Li X, Jin M, Liu Y, et al
    Identification of potential biomarkers and their correlation with immune infiltration cells in schizophrenia using combinative bioinformatics strategy.
    Psychiatry Res. 2022;314:114658.
    PubMed         Abstract available

  8. SHIMADA T, Ito S, Makabe A, Yamanushi A, et al
    Aerobic exercise and cognitive functioning in schizophrenia: An updated systematic review and meta-analysis.
    Psychiatry Res. 2022;314:114656.
    PubMed         Abstract available

  9. RIBOLSI M, Albergo G, Fiori Nastro F, Pelle M, et al
    Autistic symptomatology in UHR patients: A preliminary report.
    Psychiatry Res. 2022;313:114634.
    PubMed         Abstract available

  10. NGUYEN T, Frayne J, Watson S, Lebedevs T, et al
    Long-acting injectable antipsychotic treatment during pregnancy: Outcomes for women at a tertiary maternity hospital.
    Psychiatry Res. 2022;313:114614.
    PubMed         Abstract available


    Psychol Med

  11. DE HAAN L, Linszen D, Wouters L, Zwinderman K, et al
    Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial.
    Psychol Med. 2022 Jun 8:1-8. doi: 10.1017/S003329172200099.
    PubMed         Abstract available

  12. RABALLO A, Poletti M, Preti A
    Do antidepressants prevent transition to psychosis in individuals at clinical high-risk (CHR-P)? Systematic review and meta-analysis.
    Psychol Med. 2022 Jun 3:1-11. doi: 10.1017/S0033291722001428.
    PubMed         Abstract available


    Schizophr Res

  13. ORTIZ BB, Gadelha A, Bressan RA
    Should we rethink how we introduce schizophrenia?
    Schizophr Res. 2022;244:134.
    PubMed        

  14. SEGURA AG, Martinez-Pinteno A, Gasso P, Rodriguez N, et al
    Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort.
    Schizophr Res. 2022;244:101-110.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: